IP Library Granted Patent US 9,597,367
Granted Patent B2
US 9,597,367 · App. 14/256,323 · Granted Mar 21, 2017

Methods for improving muscle and heart function

Inventors: Robert R. Wolfe (Little Rock, AR); Jeanne Wei (Little Rock, AR)
Assignee: BIOVENTURES, LLC
A61K38/10A23L33/175A61K31/197A61K31/198A61K38/164
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,367
App. No.
14/256,323
Granted
Mar 21, 2017
Kind
B2
Abstract

The present invention encompasses combinations comprising a plurality of amino acids, formulations thereof for use in humans and animals, as well as methods for increasing muscle protein synthesis, muscle strength, and/or muscle function in a subject with chronic heart failure, cardiac cachexia or a combination thereof.

Claims (5)

1. A method for increasing muscle protein synthesis, increasing muscle strength, increasing muscle function, or a combination thereof, the method comprising administering to a subject with chronic heart failure, cardiac cachexia or a combination thereof a combination comprising phenylalanine, valine, threonine, tryptophan, methionine, leucine, isoleucine, lysine, histidine, citrulline and L-carnitine in a w/w ratio of about 4:about 6:about 5:about 2:about 2:about 25:about 7:about 10:about 1:about 8:about 3, respectively, and biotin, omega-3 fatty acids, or a combination thereof.

2. The method of claim 1 , wherein the combination is the combination listed in Table B.

3. The method of claim 1 , wherein the subject is a human.

4. The method of claim 1 , wherein the subject is at risk of muscle atrophy.

5. The method of claim 1 , wherein the subject is also diagnosed with a disease or condition selected from the group consisting of polio, Guillan-Barre syndrome, congestive heart failure, acute coronary syndrome, cancer, sarcopenia, spinal cord injury, osteoarthritis, arthritis, stroke, malnutrition, muscular dystrophy, spinal muscular atrophy, inflammatory myopathy, a disease of the peripheral nerve, a disease of the neuromuscular junction, and a metabolic disease of the muscle.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2018
From: BIOVENTURES
To: THE AMINO COMPANY
Reel/Frame 046723/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2017
From: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS; BIOVENTURES, LLC
Reel/Frame 041007/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2017
From: BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
To: BIOVENTURES, LLC
Reel/Frame 041010/0976 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2014
From: WOLFE, ROBERT R.; WEI, JEANNE
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 032865/0473 →
Continuity (2)
Provisional Application 61814034 · Apr 19, 2013
Related Publication 20140315788A1 · Oct 23, 2014